Z-2743-2016 Class II Terminated

Recalled by Integra LifeSciences Corp. — Plainsboro, NJ

FDA device recall Z-2743-2016 was initiated by Integra LifeSciences Corp. on Jun 17, 2016 and is designated Class II. Reason for recall: Data from internal studies suggests there may be a potential that the secondary package seal integrity does not provide the level of sterility intended for Minimally Invasive Achilles Tendon Suture… The recall status is terminated (terminated Nov 7, 2017). Affected quantity: 6,729 units.

Recall details

Product Type
Devices
Report Date
Sep 14, 2016
Initiation Date
Jun 17, 2016
Termination Date
Nov 7, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,729 units

Product description

Achillon Minimally Invasive Device for Achilles Tendon Rupture Treatment The Achillon Suture System is a single use, sterile device used to treat acute Achilles tendon ruptures. The Achillon Suture System is a mini-invasive procedure indicated to teat acute Achilles tendon ruptures: Acute rupture of the Achill tendon(<10 days); Rupture located between 2 and 8 cm above calcaneum; Open or closed ruptures

Reason for recall

Data from internal studies suggests there may be a potential that the secondary package seal integrity does not provide the level of sterility intended for Minimally Invasive Achilles Tendon Suture System Achillon.

Distribution pattern

Nationwide distribution

Code information

Model #'s 19700 and 19700ND

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2743-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2743-2016. Report a data issue: hello@regdatalab.com.